GSK's China Crisis spreads

By Malcolm Moore in Beijing, and Denise Roland 9:47AM BST 22 Jul 2013 15 Comments While the move comes amid a criminal investigation into GlaxoSmithKline, AstraZeneca said it does not believe it has yet been caught up in the maelstrom surrounding its rival. Officers from the Public Security Bureau arrived at Astrazeneca's sales office in Citic Square, Shanghai, on Friday afternoon and were said to have detained one employee. "We believe that this investigation relates to an individual case and while we have not yet received an update from the Public Security Bureau, we have no reason to believe it is related to any other investigations," said a spokesman for the pharmaceutical company. The company added that it "does not tolerate any illegal or unethical conduct in our business activities." The move comes after Chinese authorities appear to be widening their probe into drug pricing beyond GlaxoSmithKline. GlaxoSmithKline chief Andrew Witty set to admit China 'scam’  19 Jul 2013 A bitter pill for Glaxo in China  20 Jul 2013 GlaxoSmithKline briefs Serious Fraud Office over China case  20 Jul 2013 China, GSK and dealing with toxic bribery claims  20 Jul 2013 British consultant detained in China's GSK probe  21 Jul 2013 Sponsored  Video: dealing with complex projects Two sources also said that Baxter International, a US pharmaceutical company, is also under investigation for possible malpractice at it...
Source: PharmaGossip - Category: Pharma Commentators Authors: Source Type: blogs